SYNERGENE THERAPEUTICS
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics. It was incorporated in 1998 and is based in Potomac, Maryland.
SYNERGENE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
Potomac, Maryland, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
10.32 M USD
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Aopia Biosciences
Aopia Biosciences is a biotechnology business focused on developing cutting-edge bioengineering solutions and technologies.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Meditope Biosciences
Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.
Mitra Medical Technology
Mitra Medical Technology is a biomedical company developing systems for systemic cancer therapy and diagnosis.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Tempest Therapeutics
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Current Employees Featured
Founder
More informations about "SynerGene Therapeutics"
SynerGene Therapeutics Company Profile 2024: Valuation, Funding ...
What industry is SynerGene Therapeutics in? SynerGene Therapeutics’s primary industry is Therapeutic Devices. Is SynerGene Therapeutics a private or public company? SynerGene …See details»
SynerGene Therapeutics Inc - Company Profile and News
Company profile page for SynerGene Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
SynerGene Therapeutics, Inc.
Explore SynerGene Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 2 news, and 18 literature, Drug:SGT-53, SGT-94. ... The statistics for …See details»
SynerGene Therapeutics - Contacts, Employees, Board Members, …
Organization. SynerGene Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 2. ...See details»
SYNERGENE THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNERGENE THERAPEUTICS, INC. of Annapolis, MD. Get the latest business insights from Dun & Bradstreet.See details»
SynerGene Therapeutics Overview | SignalHire Company Profile
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics. It was incorporated in 1998 and is based in …See details»
SynerGene Therapeutics - Crunchbase
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
SynerGene Therapeutics - Craft
SynerGene Therapeutics is a biopharmaceutical company that develops targeted diagnostics and therapeutics solutions. The company focuses on the areas of cancer, vaccine delivery, and …See details»
Synergene Therapeutics - highergov.com
Federal contract and grant recipient SYNERGENE THERAPEUTICS INC (UEI WY76BLRBNNN7) is headquartered in Annapolis MD. Its primary registered NAICS is 541713 Research and …See details»
SYNERGENE THERAPEUTICS INC - CAGE.report
SYNERGENE THERAPEUTICS INC DUNS 072898005 / 07-289-8005 SYNERGENE THERAPEUTICS, INC. NCAGE Code: 43DC1. SYNERGENE THERAPEUTICS INC. CAGE …See details»
Synergene Therapeutics Inc | www.inknowvation.com
Dec 6, 2017 SynerGene Therapeutics, Inc. is a biopharmaceutical company developing targeted diagnostics and therapeutics in the areas of cancer, vaccine delivery, and neurological …See details»
SynerGene Therapeutics - Products, Competitors, Financials, …
SynerGene Therapeutics is a biopharmaceutical company that is developing targeted diagnostics and therapeutics in the areas of cancer, vaccine delivery, and neurological disorders. …See details»
Synergene Therapeutics, Inc. in Potomac, Maryland - EIN TaxId
Synergene Therapeutics, Inc. is a corporation in Potomac, Maryland. The employer identification number (EIN) for Synergene Therapeutics, Inc. is 522083516. EIN for organizations is …See details»
Organization | SynerGene Therapeutics, Inc.
Organization Overview. First Clinical Trial. 2008 NCT00470613. First Marketed Drug. None First NDA Approval. None Last Known Activity ... SynerGene Therapeutics, Inc. Active Ingredients. …See details»
Patents Assigned to SynerGene Therapeutics, Inc.
Nov 2, 2006 Assignees: SynerGene Therapeutics, Inc., Georgetown University Inventors: Liang Xu, Cheng-Cheng Huang, William Alexander, WenHua Tang, Esther H. Chang Antibody …See details»
Synergene Therapeutics (W8E3G5851JK4) - highergov.com
Synergene Therapeutics (UEI W8E3G5851JK4, CAGE 43DC1) based in Annapolis MD federal contracts, grants, registrations, vehicles, partnerships, and analysis. Description. ... For Profit …See details»
SGT-94 - Drug Targets, Indications, Patents - Synapse
Jul 15, 2023 Abstract Purpose: RB94, a truncated form of RB110, has enhanced tumor suppressor potency and activity against all tumor types tested to date including bladder …See details»
SynergeneAPI – Synergene Active Ingredients
Synergene Active Ingredients Private Limited, incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of …See details»
SGT-53 - Drug Targets, Indications, Patents - Synapse
SGT-53: a P53 gene stimulants, Apoptosis stimulants, Gene transference Drug, Initially developed by SynerGene Therapeutics, Inc., Now, its global highest R&D status is …See details»
TP53 Gene Therapy as a Potential Treatment for Patients with …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... J.B.H. and S.S.K. are employees of …See details»